Quest Diagnostics, Inc.

NYSE:DGX  
138.97
+0.58 (+0.42%)
Other Pre-Announcement

Quest Diagnostics Updates Outlook For Full Year 2020

Published: 09/10/2020 10:53 GMT
Quest Diagnostics, Inc. (DGX) - Quest Diagnostics Updates Outlook for Full Year 2020.
Revenues for Full Year 2020 Now Expected to Be $8.4-8.8 Billion Compared to Previous Outlook of $8.0-8.6 Billion.
Reported Diluted Earnings per Share (eps) for Full Year 2020 Now Expected to Be $7.42-$8.92.
Adjusted Diluted EPS for Full Year 2020 Now Expected to Be $7.50-$9.00 Compared to Previous Outlook of $6.60-$8.60.
FY2020 Earnings per Share View $8.51, Revenue View $8.72 Billion -- Refinitiv Ibes Data (analyst estimates).
Quest Diagnostics - Cash Provided by Operations for FY 2020 Now Expected to Be at Least $1.45 Billion Compared to Previous Outlook of at Least $1.25 Billion.
Quest Diagnostics - Since July 23, Organic Testing Volumes in Base Business Continued to Recover Faster Than Anticipated Through End of August.
Covid-19 Molecular and Antibody Testing Volumes Remain Consistent With Company's Previous Outlook.
Quest Diagnostics - Organic Base Testing Volumes Declined High Single Digits in July,mid-to-high Single Digits in Aug Percentage Basis Versus Prior Year.